Nifty 50
- TCS₹2,333.3084.90 (3.78%)
- ICICI Bank₹1,424.60-18.40 (-1.28%)
- HCL Technologies₹1,318.2036.20 (2.82%)
- Tata Steel₹184.48-2.32 (-1.24%)
- Infosys₹1,138.3027.50 (2.48%)
- Shriram Finance₹1,087.40-13.60 (-1.24%)
- Tech Mahindra₹1,623.8038.80 (2.45%)
- Asian Paints₹2,599.40-31.60 (-1.20%)
- Wipro₹180.674.27 (2.42%)
- Bajaj Finserv₹1,987.90-23.10 (-1.15%)
- Bajaj Auto₹11,912192.00 (1.64%)
- SBI Life Insurance ₹1,755-18.20 (-1.03%)
- Apollo Hospitals₹8,895.5095.50 (1.09%)
- UltraTech Cement₹11,597-120.00 (-1.02%)
- Trent₹2,898.9020.40 (0.71%)
- ITC₹266.25-2.75 (-1.02%)
- HDFC Bank₹715.654.65 (0.65%)
- Eicher Motors₹8,025-75.00 (-0.93%)
- Power Grid Corp₹266.151.25 (0.47%)
- Tata Consumer ₹1,032.50-9.50 (-0.91%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Symbiotec Pharmalab IPO Allotment Status: Check Symbiotec Pharmalab Allotment Status, Subscription Data and Online Share Allocation
Authored By HDFC SKY | Published at: Aug 28, 2026 12:55 PM IST
Symbiotec Pharmalab IPO allotment status is awaited after the ₹1,757 crore issue was subscribed 75.08 times, with investors able to check allocation through BSE, NSE and MUFG Intime.

Open Free Demat Account
Open Free Demat Account
Mumbai, August 28: Following the close of the subscription period, Symbiotec Pharmalab IPO allotment status is awaited after the ₹1,757 crore issue was subscribed 75.08 times overall. The QIB portion was subscribed 181.20 times, NII 77.56 times and retail 13.69 times.
The IPO closed on August 27 2026, while the allotment is expected to be finalised on August 28 2026. Investors can check their application status through the registrar, BSE or NSE using their PAN, application number or demat details.
The issue comprised a fresh issue of 15.21 lakh shares aggregating to ₹150 crore and an offer for sale of 1.63 crore shares aggregating to ₹1,607 crore. The IPO had a price band of ₹938 to ₹988 per share, with the final issue price fixed at ₹988 per share.
Steps To Check Symbiotec Pharmalab IPO Allotment Status On NSE, BSE And Registrar
Investors can check their Symbiotec Pharmalab IPO allotment status online once the allotment information is made available.
Check Symbiotec Pharmalab IPO Allotment Status on Registrar Website
MUFG Intime India Private Limited is the registrar to the issue. Investors can check the allotment by following these steps:
- Open the official MUFG Intime IPO allotment page: MUFG Intime IPO Allotment Status
- Select Symbiotec Pharmalab from the company list.
- Choose the relevant search option, such as PAN, application number or DP ID and Client ID.
- Enter the required details.
- Submit the form to view the allotment status.
Check Symbiotec Pharmalab IPO Allotment Status on BSE
Investors can check their application status through the BSE website.
- Visit the BSE IPO application status page: BSE IPO Application Status
- Select the relevant IPO.
- Enter the application number or PAN details.
- Submit the information to check the allotment result.
Check Symbiotec Pharmalab IPO Allotment Status on NSE
Investors can also use the NSE IPO bid verification facility.
- Visit the NSE IPO bid verification page: NSE IPO Bid Verification
- Select the relevant IPO.
- Enter the PAN or application details as required.
- Submit the details to check the available allotment information.
Once the allotment is released, investors will be able to see the number of shares allotted to them or an indication of no allotment.
Alternative Methods To Check Symbiotec Pharmalab IPO Allotment Status
Investors can also check their demat account after the share credit process is completed. The status of the bank account or UPI mandate can also indicate whether funds have been released after the allotment process.
The registrar remains the direct source for checking the application-wise allotment result.
Symbiotec Pharmalab IPO Subscription Status Summary
Symbiotec Pharmalab IPO received strong demand across investor categories, with the issue subscribed 75.08 times overall.
| Investor Category | Subscription |
| QIB | 181.20x |
| NII | 77.56x |
| Retail | 13.69x |
| Employees | 16.32x |
| Total | 75.08x |
The IPO received a total of 52,87,440 applications. The QIB segment recorded the highest subscription at 181.20 times, while the NII category was subscribed 77.56 times.
The IPO was open from August 24 2026 to August 27 2026. The issue carried a lot size of 15 shares, with the price band set at ₹938 to ₹988 per share.
Symbiotec Pharmalab IPO Listing Date
The tentative listing date for Symbiotec Pharmalab shares on BSE and NSE is September 1 2026.
What Happens After Symbiotec Pharmalab IPO Allotment?
The Symbiotec Pharmalab IPO allotment is expected to be finalised on August 28 2026. Investors who receive shares are expected to see them credited to their demat accounts by August 31 2026.
For investors who do not receive shares, the blocked application amount is expected to be released or refunded on August 31 2026, subject to the applicable processing timeline.
The shares are scheduled for listing on September 1 2026, subject to final confirmation from BSE and NSE.
Conclusion
Symbiotec Pharmalab IPO investors can check their allotment status through MUFG Intime, BSE and NSE once the final allotment data is released. With the issue subscribed 75.08 times overall, investors should keep their PAN, application number or demat details ready. The next key dates are allotment on August 28 2026, share credit and fund release on August 31 2026, followed by the scheduled listing on September 1 2026.
Source:
- https://www.nseindia.com/market-data/issue-information?symbol=SYMBIOTEC&series=EQ&type=Past
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
HDFC SKY from HDFC Securities, one of most trusted trading platforms in India, has been recognized with the *Next-Gen Digi Content Awards 2025–26.
More IPO News
Open Free Demat Account
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy
Join Us
Add as preferred source on Google












